Department of emergency, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Shock. 2012 Aug;38(3):301-6. doi: 10.1097/SHK.0b013e31825f6632.
Shen-Fu injection (SFI) following cardiac arrest exhibits cardioprotective effects, but its effect on myocardial dysfunction, a critical issue following resuscitation, is unclear. This study sought to examine whether SFI reduces postresuscitation myocardial dysfunction in a porcine model of cardiac arrest by modulating apoptosis. After 8 min of untreated ventricular fibrillation and 2 min of basic life support, 24 pigs were randomized divided into three groups, which received central venous injection of either Shen-Fu (SFI group; 1.0 mL/kg), epinephrine (EP group; 0.02 mg/kg), or saline (SA group). After successful return of spontaneous circulation (ROSC), hemodynamic status and blood samples were obtained at 0, 30, 120, and 360 min after ROSC. Surviving pigs were killed at 24 h after ROSC, and the hearts were removed for analysis by electron microscopy, Western blotting, quantitative real-time polymerase chain reaction, and TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assay. Compared with the EP and SA groups, animals treated with SFI had improved left ventricular function (P < 0.05), lower troponin T levels (P < 0.01), and increased tissue perfusion and oxygen metabolism (P < 0.05). Shen-Fu injection was associated with a reduction in (i) Bcl-2, Bax, and caspase 3 protein expression (P < 0.05); (ii) caspase 3 mRNA upregulation; and (iii) apoptosis, compared with the EP and SA groups. Caspase 3-mediated apoptosis occurs following myocardial injury after cardiopulmonary resuscitation in pigs. Shen-Fu injection decreased myocardial injury; improved myocardial ultrastructure; inhibited Bcl-2, Bax, and caspase 3 expression; and reduced myocardial apoptosis. Therefore, SFI could significantly attenuate postresuscitation myocardial dysfunction by modulating apoptosis.
参附注射液(SFI)在心脏骤停后表现出心脏保护作用,但它对再灌注后心肌功能障碍(复苏后一个关键问题)的影响尚不清楚。本研究旨在通过调节细胞凋亡来探讨 SFI 是否能减轻猪心脏骤停模型再灌注后心肌功能障碍。在未治疗的心室颤动 8 分钟和基础生命支持 2 分钟后,24 头猪随机分为三组,分别接受中心静脉注射参附(SFI 组,1.0 mL/kg)、肾上腺素(EP 组,0.02 mg/kg)或生理盐水(SA 组)。自主循环恢复(ROSC)成功后,在 ROSC 后 0、30、120 和 360 分钟时获取血流动力学状态和血液样本。ROSC 后 24 小时幸存的猪被处死,取出心脏进行电镜、Western 印迹、实时定量聚合酶链反应和 TUNEL(末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记)检测分析。与 EP 组和 SA 组相比,SFI 治疗组左心室功能改善(P < 0.05),肌钙蛋白 T 水平降低(P < 0.01),组织灌注和氧代谢增加(P < 0.05)。与 EP 组和 SA 组相比,SFI 组(i)Bcl-2、Bax 和 caspase 3 蛋白表达降低(P < 0.05);(ii)caspase 3 mRNA 上调;(iii)细胞凋亡减少。心脏骤停后心肺复苏引起的猪心肌损伤后发生 caspase 3 介导的细胞凋亡。参附注射液可减少心肌损伤,改善心肌超微结构,抑制 Bcl-2、Bax 和 caspase 3 的表达,减少心肌细胞凋亡。因此,SFI 通过调节细胞凋亡可显著减轻再灌注后心肌功能障碍。